ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,087,000 | -17.1% | 33,605 | +4.5% | 0.16% | -28.8% |
| Q1 2020 | $1,311,000 | -38.1% | 32,168 | -6.3% | 0.22% | -2.6% |
| Q4 2019 | $2,118,000 | -27.3% | 34,348 | -14.1% | 0.23% | -44.9% |
| Q3 2019 | $2,915,000 | -12.0% | 40,003 | -0.7% | 0.41% | +25.1% |
| Q2 2019 | $3,311,000 | -22.6% | 40,284 | -33.6% | 0.33% | -14.0% |
| Q1 2019 | $4,277,000 | +58.2% | 60,630 | +1.0% | 0.38% | +41.0% |
| Q4 2018 | $2,703,000 | -13.7% | 60,047 | +8.4% | 0.27% | +61.5% |
| Q3 2018 | $3,131,000 | +1.7% | 55,384 | +20.1% | 0.17% | -7.1% |
| Q2 2018 | $3,080,000 | +110.2% | 46,108 | +83.3% | 0.18% | +91.6% |
| Q1 2018 | $1,465,000 | -6.6% | 25,161 | +3.4% | 0.10% | -5.0% |
| Q4 2017 | $1,568,000 | -10.6% | 24,326 | -27.2% | 0.10% | -9.1% |
| Q3 2017 | $1,753,000 | +486.3% | 33,402 | +422.2% | 0.11% | +423.8% |
| Q2 2017 | $299,000 | -0.3% | 6,397 | +5.7% | 0.02% | 0.0% |
| Q1 2017 | $300,000 | -41.7% | 6,052 | -28.7% | 0.02% | -41.7% |
| Q4 2016 | $515,000 | -53.9% | 8,492 | -49.5% | 0.04% | -56.1% |
| Q3 2016 | $1,117,000 | +18.1% | 16,829 | -0.7% | 0.08% | +15.5% |
| Q2 2016 | $946,000 | +71.4% | 16,941 | +3.4% | 0.07% | +82.1% |
| Q1 2016 | $552,000 | +66.8% | 16,387 | +123.7% | 0.04% | +77.3% |
| Q4 2015 | $331,000 | +7.1% | 7,327 | -6.4% | 0.02% | 0.0% |
| Q3 2015 | $309,000 | -51.0% | 7,824 | -23.0% | 0.02% | -37.1% |
| Q2 2015 | $631,000 | -39.3% | 10,164 | -38.8% | 0.04% | -45.3% |
| Q1 2015 | $1,040,000 | – | 16,620 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Capital Management, Inc | 73 | $4,025 | 0.00% |